Recombinant human transforming growth factor β€1 (TGF-β€1) was incorporated into microparticles of blends of poly(DL-lactic-co-glycolic acid) (PLGA) and poly(ethylene glycol) (PEG) to create a delivery vehicle for the growth factor. The entrapment efficiency of TGF-β€1 in the microparticles containing
Controlled release of transforming growth factor ?1 from biodegradable polymer microparticles
β Scribed by Lu, Lichun ;Stamatas, Georgios N. ;Mikos, Antonios G.
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Volume
- 50
- Category
- Article
- ISSN
- 0021-9304
No coin nor oath required. For personal study only.
β¦ Synopsis
Recombinant human transforming growth factor β€1 (TGF-β€1) was incorporated into biodegradable microparticles of blends of poly(DL-lactic-co-glycolic acid) (PLGA) and poly(ethylene glycol) (PEG) at 6 ng/1 mg microparticles. Fluorescein isothiocynate labeled bovine serum albumin (FITC-BSA) was coencapsulated as a porogen at 4 g/1 mg of microparticles. The effects of PEG content (0, 1, or 5 wt %) and buffer pH (3, 5, or 7.4) on the protein release kinetics and the degradation of PLGA were determined in vitro for up to 28 days. The entrapment yield of TGF-β€1 was 83.4 Β± 13.1 and 54.2 Β± 12.1% for PEG contents of 0 and 5%, respectively. The FITC-BSA and TGF-β€1 were both released in a multiphasic fashion including an initial burst effect. Increasing the PEG content resulted in the decreased cumulative mass of released proteins. By day 28, 3.8 Β± 0.1 and 2.8 Β± 0.3 g (based on 1 mg microparticles) of loaded FITC-BSA and 3.4 Β± 0.2 and 2.2 Β± 0.3 ng of loaded TGF-β€1 were released into pH 7.4 phosphate buffered saline (PBS) from microparticles with 0 and 5% PEG, respectively. Aggregation of FITC-BSA occurred at lower buffer pH, which led to decreased release rates of both proteins. For microparticles with 5% PEG, 2.3 Β± 0.1 g of FITC-BSA and 2.0 Β± 0.2 ng of TGF-β€1 were released in pH 7.4 buffer after 28 days, while only 1.7 Β± 0.3 g and 1.3 Β± 0.4 ng of the corresponding proteins were released in pH 3 buffer. The degradation of PLGA was also enhanced at 5% PEG content, which was significantly accelerated at acidic pH conditions. The calculated half-lives of PLGA were 20.3 Β± 0.9 and 15.9 Β± 1.2 days for PEG contents of 0 and 5%, respectively, in pH 7.4 PBS and 14.8 Β± 0.4 and 5.5 Β± 0.1 days for 5% PEG in pH 7.4 and 3 buffers, respectively. These results suggest that PLGA/PEG blend microparticles are useful as delivery vehicles for controlled release of growth factors.
π SIMILAR VOLUMES
## Abstract Nerve growth factor (NGF) is known to promote the axonal regeneration in injured nerve system. Delivery of NGF for a long period in a controlled manner may enhance the regeneration efficacy. In this study, we investigated whether NGF can be released from fibrin gel for a long period in
## Abstract We report the results of a high throughput screening campaign that is aimed to develop a biodegradable polymerβbased formulation to deliver active keratinocyte growth factor (KGF) and provide a means to tune the KGF delivery rate. A statistical design strategy was used to prepare and sc
## Abstract A drug delivery vehicle was constructed that could be visualized noninvasively with MRI. The biodegradable polymer poly(DLβlacticβcoβglycolic acid) (PLGA) was used to fabricate microspheres containing vascular endothelial growth factor (VEGF) and the MRI contrast agent gadolinium diethy
## Abstract Coral bone graft substitutes have been supplemented in the past with growth factors to further enhance bone regeneration in defects. Little is known, however, on the dynamics of protein release from coral. Coral particles were studied for their ability to release transforming growth fac